*a copy of this letter was also sent to the House of Representatives

August 18, 2016

The Honorable Amy Klobuchar
United States Senate
302 Hart Senate Office Building
Washington, DC 20510 

The Honorable Susan Collins
United States Senate
413 Dirksen Senate Office Building
Washington, DC 20510

Dear Senator Klobuchar and Senator Collins:

We write to express our strong support for the Alzheimer's Caregiver Support Act (S.3113). This legislation would provide vital support and training to people living with Alzheimer’sdisease and other forms of dementia and to their caregivers.

Your keen understanding of dementia’s enormous personal and societal toll is demonstrated in each of the legislation’s key features. The Act addresses dementia in all its forms including Alzheimer’s disease, vascular disease, Lewy body dementia, frontotemporal degeneration, and mixed etiologies. Equally important, the Act recognizes that a one-size-fits all approach to care and quality of life must become more tailored and responsive to the heterogeneity of people facing dementia including: women, people in medically under-served areas or
ethnically and culturally diverse communities, those with intellectual and developmental
disabilities, or with younger-onset disease.

This is a time of great and deserved hope as Congress and the National Institutes of Health have begun to address chronic underfunding of research aiming for scientific breakthroughs to prevent or stop dementia in its tracks by 2025. People living with dementia want breakthroughs and many participate in clinical trails to advance the science. 

But people living with dementia today cannot rest all their hopes in what science will produce in the coming years. They need what the Act can deliver now. The Act strengthens the ability of community rooted
organizations to improve quality of life for people facing dementia today. The Act strengthens the the ability of people living with dementia and their families to access tailored, effective, person-centered services and training where and when it matters most.

We all know the public health, budgetary and macro-economic statistics about dementia. All too many people know first-hand the individual human toll. You have been vocal, powerful and effective voices for millions of people across this country whose personal stories demand attention and demand change. The Act gives voice to the fundamental truth that people living with dementia need not only hope for the future but also improved quality of life today.

Thank you for considering our views and for your commitment to overcoming Alzheimer’s disease and other forms of dementia. Please contact Ian Kremer, executive director of Leaders Engaged on Alzheimer's Disease (the LEAD Coalition),i [email protected] or (571) 383-9916, with questions or for additional information.

LEAD Leaders Engaged on Alzheimer’s Disease


Abe’s Garden
Academy of Radiology Research
ACT on Alzheimer's
African American Network
Against Alzheimer's
Paul S. Aisen, MD (Keck School of
Medicine of USC, Alzheimer's
Therapeutic Research Institute*)
Alliance for Aging Research
Alzheimer's & Dementia Alliance
of Wisconsin
Alzheimer’s Foundation of America
Alzheimer’s Greater Los Angeles
Alzheimer’s Mississippi
Alzheimer’s Orange County
Alzheimer’s San Diego
Alzheimer's Tennessee
AMDA – The Society for Post-Acute and
Long-Term Care Medicine
American Association for Geriatric
ARGENTUM | Expanding Senior Living
Laura D. Baker, PhD (Wake Forest School
of Medicine*)
Banner Alzheimer’s Institute
David M. Bass, PhD (Benjamin Rose
Institute on Aging*)
Beating Alzheimer's by Embracing
Benjamin Rose Institute on Aging
B’nai B’rith International
Soo Borson MD (University of Washington
Schools of Medicine and Nursing*)
James Brewer, M.D., Ph.D. (UC
San Diego and Alzheimer’s
Disease Cooperative Study*)
BrightFocus Alzheimer’s
Disease Research
Christopher M. Callahan, MD
(Indiana University Center for
Aging Research*)
Caregiver Action Network
Center for Alzheimer Research
and Treatment, Harvard Medical School
Center for BrainHealth at The University of
Texas at Dallas
Sandra Bond Chapman, PhD (Center for
BrainHealth at The University of Texas
at Dallas*)
Coalition for Imaging and Bioengineering
CorTechs Labs
Critical Path Institute/ Coalition Against
Major Diseases
Cure Alzheimer’s Fund
Darrell K. Royal Fund for
Alzheimer's Research
Dementia Alliance International
Dementia Friendly America
Department of Neurology, Washington
University School of Medicine
Rachelle S. Doody, MD, PhD
(Baylor College of Medicine*)
Gary Epstein-Lubow, MD (Alpert Medical
School of Brown University*)
Sam Gandy, MD, PhD (Icahn School of
Medicine at Mount Sinai*)
Joseph E. Gaugler, Ph.D. (School of
Nursing, Center on Aging, University of
Geoffrey Beene Foundation Alzheimer’s
Georgetown University Medical Center
Memory Disorders Program
Georgia Institute on Aging
Gerontological Society of America
Laura N. Gitlin, PhD (Johns Hopkins
School of Medicine*)
Lisa P. Gwyther, MSW, LCSW
(Duke University Medical Center*)
David Holtzman, MD
(Washington University School of
Medicine, Department of Neurology*)
Huffington Center on Aging
Indiana University Center for
Aging Research
Janssen R&D
Kathy Jedrziewski, PhD (University of
Johns Hopkins Memory and Alzheimer's
Treatment Center
Johns Hopkins School of Nursing Center
for Innovative Care in Aging
Katherine S. Judge, PhD (Cleveland State
Keck School of Medicine of USC,
Alzheimer's Therapeutic Research
Walter A. Kukull, PhD (School of Public
Health, University of Washington*)
Latino Alzheimer’s and Memory Disorders
Lewy Body Dementia Association
Linked Senior, Inc.
LuMind Research Down
Syndrome Foundation
Lutheran Services of America
Kostas Lyketsos, M.D., M.H.S. (Johns
Hopkins Memory and Alzheimer's
Treatment Center*)
David G. Morgan, PhD (USF Health Byrd
Alzheimer's Institute*)
Mount Sinai Center for Cognitive Health
National Alliance for Caregiving
National Asian Pacific Center on Aging
National Association of Activity
National Association of Nutrition and Aging
Services Programs
National Association of States United for
Aging and Disabilities
National Caucus and Center on Black
Aged, Inc. (NCBA)
National Committee to Preserve Social
Security and Medicare
National Consumer Voice for Quality Long-
Term Care
National Council for Behavioral Health
National Down Syndrome Society
National Hispanic Council On
Aging (NHCOA)
National Task Group on
Intellectual Disabilities and
Dementia Practices
Neurotechnology Industry Organization
NFL Neurological Center
NYU Alzheimer's Disease Center
NYU Langone Center on Cognitive
NYU Langone Medical Center
Noah Homes
OWL-The Voice of Women 40+
Pat Summitt Foundation
Pioneer Network
Piramal Imaging S.A.
Presence Care Project
Prevent Alzheimer’s Disease 2020
Eric Reiman, MD (Banner Alzheimer's
Stephen Salloway, M.D.,
M.S. (The Warren Alpert Medical
School of Brown University*)
Second Wind Dreams, Inc./
Virtual Dementia Tour
Reisa A. Sperling, MD, MMSc (Center for
Alzheimer Research and Treatment,
Harvard Medical School*)
Rudolph Tanzi, PhD (Department of
Neurology, MGH/Harvard Medical
The Association for Frontotemporal
The Eden Alternative
The Evangelical Lutheran Good Samaritan
The Youth Movement Against Alzheimer’s
Geoffrey Tremont, Ph.D., ABPPCN
(Alpert Medical School of
Brown University*)
R. Scott Turner, MD, PhD (Georgetown
University Memory Disorders Program*)
UsAgainstAlzheimer’s, LEAD Coalition coconvener
USF Health Byrd Alzheimer's Institute
Volunteers of America, LEAD Coalition coconvener
Nancy Wilson, MA LCSW (Baylor College
of Medicine*)

* Affiliations of individual researchers are for identification purposes only and do not necessarily represent the endorsement of the affiliated institution.

Leaders Engaged on Alzheimer’s Disease (the LEAD Coalition) is a diverse national coalition of member organizations including patient advocacy and voluntary health non-profits, philanthropies and foundations, trade and professional associations, academic research and clinical institutions, and home and residential care providers, and biotechnology and pharmaceutical companies. The LEAD Coalition works collaboratively to focus the nation’s strategic attention on dementia in all its causes — including Alzheimer’s disease, vascular disease, Lewy body dementia, and frontotemporal degeneration — and to accelerate transformational progress in detection and diagnosis, care and support, and research leading to prevention, effective treatment and eventual cure. One or more participants may have a financial interest in the subjects addressed.